Total Payments
$19,577
2024 Payments
$19,558
Companies
2
Transactions
29
Medicare Patients
1,110
Medicare Billing
$144,862
Payment Breakdown by Category
Other$11,718 (59.9%)
Consulting$5,780 (29.5%)
Travel$1,559 (8.0%)
Food & Beverage$518.77 (2.6%)
Education$1.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,600 | 6 | 49.0% |
| Consulting Fee | $5,780 | 1 | 29.5% |
| Compensation for serving as faculty or as a speaker for a medical education program | $2,118 | 3 | 10.8% |
| Travel and Lodging | $1,559 | 7 | 8.0% |
| Food and Beverage | $518.77 | 11 | 2.6% |
| Education | $1.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $10,446 | 12 | $0 (2024) |
| Eisai Inc. | $9,130 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,558 | 28 | Lilly USA, LLC ($10,446) |
| 2023 | $18.08 | 1 | Eisai Inc. ($18.08) |
All Payment Transactions
29 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $770.00 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $962.50 | General |
| Category: Neurology | ||||||
| 11/06/2024 | Eisai Inc. | Leqembi (Drug) | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | $385.00 | General |
| Category: Neurology | ||||||
| 11/05/2024 | Lilly USA, LLC | KISUNLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: Neuroscience | ||||||
| 10/25/2024 | Lilly USA, LLC | KISUNLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: Neuroscience | ||||||
| 10/25/2024 | Lilly USA, LLC | KISUNLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $98.57 | General |
| Category: Neuroscience | ||||||
| 10/03/2024 | Eisai Inc. | Leqembi (Drug) | Consulting Fee | Cash or cash equivalent | $5,780.00 | General |
| Category: Neurology | ||||||
| 10/01/2024 | Lilly USA, LLC | KISUNLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: Neuroscience | ||||||
| 10/01/2024 | Lilly USA, LLC | KISUNLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: Neuroscience | ||||||
| 09/26/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $121.13 | General |
| Category: Neuroscience | ||||||
| 09/21/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $92.42 | General |
| Category: Neurology | ||||||
| 09/21/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $78.35 | General |
| Category: Neurology | ||||||
| 09/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $49.89 | General |
| Category: Neurology | ||||||
| 09/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $49.71 | General |
| Category: Neurology | ||||||
| 09/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $18.80 | General |
| Category: Neurology | ||||||
| 09/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $14.09 | General |
| Category: Neurology | ||||||
| 09/21/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $13.20 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $465.12 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $222.31 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Eisai Inc. | Leqembi (Drug) | Travel and Lodging | Cash or cash equivalent | $122.41 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $71.44 | General |
| Category: Neurology | ||||||
| 09/20/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $17.01 | General |
| Category: Neurology | ||||||
| 09/19/2024 | Lilly USA, LLC | KISUNLA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,400.00 | General |
| Category: Neuroscience | ||||||
| 09/12/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $271.52 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 338 | 347 | $104,883 | $45,871 |
| 2022 | 6 | 273 | 324 | $122,450 | $34,976 |
| 2021 | 6 | 284 | 391 | $133,398 | $41,571 |
| 2020 | 5 | 215 | 244 | $85,064 | $22,443 |
Total Patients
1,110
Total Services
1,306
Medicare Billing
$144,862
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 119 | 119 | $43,197 | $19,054 | 44.1% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 50 | 54 | $24,624 | $10,874 | 44.2% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2023 | 118 | 118 | $21,476 | $8,170 | 38.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 34 | $8,568 | $4,532 | 52.9% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 22 | 22 | $7,018 | $3,241 | 46.2% |
| 99483 | Assessment of and care planning for impaired thought processing, typically 50 minutes | Office | 2022 | 56 | 59 | $28,910 | $8,556 | 29.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 43 | 64 | $20,130 | $7,123 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 48 | 75 | $20,000 | $6,163 | 30.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 40 | 40 | $17,665 | $5,233 | 29.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 34 | 34 | $20,525 | $4,685 | 22.8% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2022 | 52 | 52 | $15,220 | $3,216 | 21.1% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 57 | 94 | $28,665 | $11,344 | 39.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 118 | $31,060 | $10,920 | 35.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 50 | 51 | $30,570 | $7,179 | 23.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 54 | 54 | $22,875 | $7,084 | 31.0% |
| 96116 | Neurobehavioral status examination by qualified health care professional with interpretation and report, first 60 minutes | Office | 2021 | 58 | 62 | $18,428 | $4,172 | 22.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 11 | 12 | $1,800 | $873.31 | 48.5% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 64 | 74 | $31,878 | $7,329 | 23.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 67 | 73 | $16,750 | $5,946 | 35.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 35 | 47 | $12,501 | $4,054 | 32.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 34 | 34 | $19,175 | $3,955 | 20.6% |
| 96116 | Neurobehavioral status examination by qualified health care professional with interpretation and report, first 60 minutes | Office | 2020 | 15 | 16 | $4,760 | $1,160 | 24.4% |
About Daniel Lee
Daniel Lee is a Psychiatry healthcare provider based in Columbus, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2014. The National Provider Identifier (NPI) number assigned to this provider is 1821415753.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Lee has received a total of $19,577 in payments from pharmaceutical and medical device companies, with $19,558 received in 2024. These payments were reported across 29 transactions from 2 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($9,600).
As a Medicare-enrolled provider, Lee has provided services to 1,110 Medicare beneficiaries, totaling 1,306 services with total Medicare billing of $144,862. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Columbus, OH
- Active Since 03/28/2014
- Last Updated 08/02/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1821415753
Products in Payments
- KISUNLA (Drug) $9,820
- Leqembi (Drug) $9,130
- AMYVID (Drug) $46.85
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Columbus
Fred Romeo, Md, MD
Psychiatry — Payments: $2.3M
Psychiatry $2.3M
Michael Saribalas
Psychiatry — Payments: $1.3M
Psychiatry $1.3M
Kevin Ware, Md, MD
Psychiatry — Payments: $1.1M
Psychiatry $1.1M
Dr. Peter Zafirides, Md, MD
Psychiatry — Payments: $127,832
Psychiatry $127,832
Dr. Benjamin Roy, M.d, M.D
Psychiatry — Payments: $102,125
Psychiatry $102,125
Barbara Gracious, M.d, M.D
Psychiatry — Payments: $58,986
Psychiatry $58,986